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Abstract

Background: Birth weight has been identified as a birth-related factor associated with the risk of breast cancer.
However, the evidence is inconsistent.
Methods: To investigate the association between birth weight and breast cancer, we conducted a metaanalysis of published studies between 1996 and 2008. Eighteen studies encompassing 16,424 breast cancer
cases were included in the meta-analysis. Data were combined using a fixed-effect or random-effect model
depending on the heterogeneity across studies.
Results: Women with their own birth weight >4000 g or 8.5 lb had a higher risk for developing breast cancer
than those with birth weight(OR¼1.20, 95% CI 1.08, 1.34). Findings were also consistent with a doseresponse pattern effect. The summary effect estimate for breast cancer risk per 1 kg increase in birth weight
was statistically significant (random effects OR¼1.07, 95% CI 1.02, 1.12).
Conclusions: Although these results provided no evidence indicating whether birth weight is more strongly
related to early-onset than to later-onset breast cancer, our findings suggest an association between birth
weight and breast cancer. The underlying biological mechanism relating to this phenomenon needs additional
study.
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Abstract

Background: Birth weight has been identified as a birth-related factor associated with the risk of breast cancer.
However, the evidence is inconsistent.
Methods: To investigate the association between birth weight and breast cancer, we conducted a meta-analysis
of published studies between 1996 and 2008. Eighteen studies encompassing 16,424 breast cancer cases were
included in the meta-analysis. Data were combined using a fixed-effect or random-effect model depending on
the heterogeneity across studies.
Results: Women with their own birth weight >4000 g or 8.5 lb had a higher risk for developing breast cancer
than those with birth weight <2500 g or 3000 g (OR ¼ 1.20, 95% CI 1.08, 1.34). Findings were also consistent with
a dose-response pattern effect. The summary effect estimate for breast cancer risk per 1 kg increase in birth
weight was statistically significant (random effects OR ¼ 1.07, 95% CI 1.02, 1.12).
Conclusions: Although these results provided no evidence indicating whether birth weight is more strongly
related to early-onset than to later-onset breast cancer, our findings suggest an association between birth weight
and breast cancer. The underlying biological mechanism relating to this phenomenon needs additional study.

Introduction

B

reast cancer is the most commonly diagnosed malignant neoplasm among females in the United States, accounting for one of every three cancer diagnoses, with the
highest incidence among women >age 50.1 In 2007, over
40,000 women died of breast cancer in the United States. Although the incidence of breast cancer has decreased slightly
in recent years, an estimated 178,480 new invasive cases of
breast cancer, including 62,030 new cases of in situ breast
cancer, were expected to occur annually among women.1,2
Epidemiological, clinical, and genetic studies have identified a
number of biological and social traits as risk factors of breast
cancer. These factors include familial history of breast cancer,
age, higher socioeconomic status, ionizing radiation, tallness
in adult life, alcohol consumption, susceptibility genes of
breast cancer 1 (BRCA1) and breast cancer 2 (BRCA2), and a
variety of hormonal and metabolic factors.3 However, these
well-established risk factors for female breast cancer do not
sufficiently elucidate the incidence pattern of this cancer, and
additional risk factors have to be considered to advance our

understanding of breast carcinogenesis and suggest future
intervention strategies.
Evidence has suggested that the prenatal period may be
particularly relevant for the development of future adult
breast cancer. Results from animal experiments and migrant
population studies support the potential influence of prenatal
life exposures on subsequent breast cancer development.4–7
Trichopoulos8 hypothesized that prenatal factors, such as
elevated hormone concentrations in utero, may increase subsequent breast cancer risk. There are methodological and theoretical challenges that these studies face, however, including
the long induction period between exposure and disease as
well as lack of assurance about the critical time window of
exposure. Several epidemiological studies have since linked
birth weight as a marker of in utero environment with breast
cancer risk. Some studies have reported high birth weight as a
breast cancer risk factor,9–17 although other studies have not
supported this relationship.18–24
Despite the relatively large number of studies, the evidence
of an association between birth weight and breast cancer is
inconclusive. Thus, combining data across these studies is
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useful to determine the overall statistical pattern of evidence.
Three previous meta-analyses have been conducted to evaluate the association between birth weight and breast cancer.25–27 However, these studies inadequately addressed the
dose-responselike relationship between birth weight and
breast cancer (i.e., risk of breast cancer per 1 kg increase in
birth weight), and there are also concerns about heterogeneity
across studies that were not accounted for. A pooled analysis
of individual participant data was published in 2008,28 and
although the results of this study are important, the pooled
analysis method limited the number of studies that could he
used to conduct a trend analysis based on continuous data.
The World Cancer Research Fund (WCRF) report, launched in
November 2007, examined breast cancer risk per 1 kg increase
in birth weight but included only six cohort studies.29 In addition, although the meta-analysis conducted by Michels
and Xue27 included analysis of potential effect modification
by menopausal status, there were a few questions about the
selection of studies, compatible birth weight category, and the
analytical methods related to this analysis.
This meta-analysis provides new information on the doseresponselike relationship between birth weight and breast
cancer risk while also examining effect modification by
menopausal status in detail. The primary aims of this metaanalysis were (1) to determine the overall risk for breast cancer
of the highest birth weight (4000 g or 8.5 lb) compared
with the lowest birth weight (<2500 g or 3000 g), (2) to assess
whether the association followed a dose-responselike pattern,
and (3) to determine if the association could be discerned
separately for women with breast cancer diagnosed at premenopausal or postmenopausal status.
Materials and Methods
Study identification
We performed a systematic literature search of PUBMED,
EMBASE, and GOOGLE SCHOLAR Search Engine (scholar
.google.com) through 2008 to identify epidemiological studies
of the association between birth weight and breast cancer. We
used the index terms birth weight, breast cancer, risk factors,
and epidemiology in various combinations. A manual review
of references from primary or review articles was performed to
identify any additional relevant studies. The studies included
in the meta-analysis were systematically selected based on the
following criteria: (1) studies were peer-reviewed and published in English, (2) studies provided measures of odds ratios (OR) or relative risk (RR) (e.g., unadjusted or adjusted
ORs) for breast cancer or the number of individuals (both cases
and controls or both cases and person-years) in different birth
weight strata as well as an indication of the uncertainty of the
central estimate (e.g., 95% confidence interval [CI]) corresponding to birth weight strata, and (3) studies with more comprehensive covariate adjustment, focused on breast cancer, or
with compatible categorization of birth weight were preferred.
From a review of abstracts identified in the database search,
32 articles were selected for a full review after excluding review articles, studies of other risk factors, and commentary.
We further excluded 14 studies of the total of 32 studies. Two
studies did not provide adequate information for either dichotomous comparisons or trend analysis,21,30 2 twins studies
were excluded because we were concerned with differences
between twins and general birth populations, particularly with
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regard to birth weight,31,32 and 10 other studies were excluded
because their results were included in other detailed publications that provided more comprehensive results or adequate
information.10,16,17,19,20,22,33–36 Thus, the present meta-analysis
includes 18 unique studies: 11 case-control studies,9,13,18,23,37–43
and 7 cohort studies11,12,14,15,24,44,45 (Tables 1 and 2).
Data were extracted using standardized data extraction
forms. For each study, extracted information included study
country and year, study design, population characteristics
(country and age), source of birth weight information, number of cases, sample size, unadjusted or adjusted ORs, and
95% Cl in different birth weight strata. In addition, matching
factors for cases and controls and factors for which statistical
adjustment was performed were extracted.
Statistical analysis
Dichotomous comparisons. To obtain the association
between high birth weight (i.e., 4,000 g or 8.5 lb) and risk of
breast cancer across studies, we used the lowest birth weight
stratum as the reference group, a standard that most of the
studies applied. A majority of the included studies used a
birth weight cutoff of <2500 g or <5.5 lb as the lowest birth
weight stratum. Only a few studies used a birth weight cutoff
of <3000 g as the lowest birth weight stratum.12,14,37,45 For the
statistical synthesis, the covariate adjusted ORs or RRs were
used if they were provided. If not, we used the raw data to
calculate the unadjusted OR or RR for the studies that used a
reference other than the lowest birth weight stratum or that
had no estimates for all age groups, if appropriate. To assess
the effects of birth weight on early-onset and later-onset breast
cancer, the dichotomous ORs or RRs were extracted separately for premenopausal and postmenopausal women if the
data were available.
Trend analysis for unadjusted or adjusted strength of
association. To obtain a uniform measure of the trend, the
change in breast cancer risk per 1 kg increase in birth weight
was extracted from each study when the information was
provided. Otherwise, we used the method of corrected
for covariance of log RR described by Greenland and Longnecker46 to quantify the change in risk per 1 kg increase in
birth weight for studies that provided information for three or
more birth weight strata. In this method, the regression coefficient and its Cls between the risk of breast cancer on the
logit scale and the median of birth weight in each category
were obtained. The ORs or RRs for the change in risk per 1 kg
increase in birth weight were estimated by exponentiation of
the regression coefficient.47,48
Meta-analysis: Estimations of summary effects and
heterogeneity evaluation. Each study contributed measures
of ORs or RRs of breast cancer comparing highest birth weight
to lowest birth weight for women of all ages, or separately by
menopausal status, or ORs or rate ratios per 1 kg increase in
birth weight (separately by menopausal status, if available).
As a summary estimate, we used the general variance-based
method, which provides an inverse variance weighted average of the study-specific estimates, to calculate the summary
effect estimate for either the dichotomous ORs or ORs per 1 kg
increase in birth weight. This summary effect estimate represents a weighted average estimate of the effect of birth
weight on breast cancer across the studies.

1996 Case-control

2002 Case-control

2004 Cohort study

Sanderson=USA39

Sanderson=China18

dos Santos Silva=UK14

2002 Case-control

2002 Case-control

Questionnaire

Midwives’ reports

Cancer registry=population
control
Cancer registry=licensed
drivers and Medicare
beneficiaries

Cancer registry=population
control
NCI DES cohort

Cancer registry=population
control
Cancer registry=
population-based cohort
Cancer registry=
population control

Born 1949 or later, age 18–74

Diagnosed 1996–2001,
age 35–80

Diagnosed 1996–1998,
age 25–64
Born 1946

Diagnosed 1983–1990

Diagnosed 2000–2003,
age 20–74

Diagnosed 1943–1990,
age <40
1992–2002 in NHS
and 1991–2001 in
NHS II

Born 1874–1961,
Diagnosed 1958–1994
Born 1924–1933
Diagnosed 1978–1995,
age 14–37
Born 1924–1950,
age >55 years
Born 1915–1929

Born 1914, 1948,
1922, 1930
Born 1930–1975

Case recruitment
period

Questionnaire
Diagnosed 1978–2001
and obstetrical charts
Birth record
Born 1910 and 1970,
age 27–83
Interview
Diagnosed 1992–1994

Birth record

Self-reported

Medical record

Interview

Hospital records and cancer Interview
registry=population-based
control
Cancer registry=population Questionnaire
control

Cancer registry=
population control
NHS cohort

Medical record

Birth record

Hospital record
Birth record

Medical record

School health records

Medical record

Birth weight source

1,716

373

97

196

845

59

288

1,147

2,386

3,140

894

63

89

177
484

1,068

3,340

62

3,602

1,523

118,985

363

2,383

2,176

638

2,546

4,888

136,466

4,317

5,062

327

3,447
3,354

2,727

3,333,359

1,080

No.
of cases Sample size

A, AM, BC, P, AFB,
BMI, FHBC,
HBBD, P, OC,
AC, PAC
A, EDU, AM, MPS,
AMP, AFB, CH,
FHBC, MGS, BMI
A, FHBC, MPS,
AM, BY, RY, AFB,
BMI, IF, OC, MSK,
MA, BO
A, IN, FHBC, HF,
AM, P, AFB
A

GA, BC, MP,
BO, P, AM
APG, AM, H,
BMI_14
A, MSES, P, TM,
NJ, SP, MP
NA
GA, MP, AP, MG,
P, MA, PA, R
GA, BY, MP, O,
BMI_A, EDU
GA, MS, CH, AFM,
EDU, PCP, O
MS, MA, BO

Adjusting factorsa

Year of birth,
residency
NA

A, Place

AFB, P

Frequency-matched: A, EDU, R, BMI,
age, race, and
HBBD, FHBC,
residence
AM, AMP, P,
L, AFB
Frequency match:
A, R, MA, BMI_A,
age and race
SF, HB
NA
A, GA

Frequency match:
age
NA

Frequency
match: age
and residence
Frequency
match: age
and residence

Midwife
and time of birth
NA

NA

Age

Hospital
and date of birth
NA
Residence

NA

NAa

Matching factors

a
A, age; AC, alcohol consumption; AFB, age at first birth; AFM, age at first marriage; AM, age at menarche; AMP, age at menopause; AP, abruptio placentae; APG, age at peak growth; BC, birth
cohort; BMI_A, adult BMI; BMI_14, BMI at 14 years; BO, birth order; BY, birth year; CH, children in the home; EDU, education; FHBC, family history of breast cancer; GA, gestational age; H, height; HB,
history of biopsy; HBBD, history of breast benign disease; HF, history of fibroadenoma; IF, infertility; IN, income; L, lactation; MA, maternal age; MG, multifetal gestation; MGS, mammography
screening; MP, maternal preeclampsia; MPS, menopausal status; MS, marital status; MSES, maternal socioeconomic status; MSK, maternal smoking; NA, not available; NJ, neonatal jaundice; O,
occupation; OC, oral contraceptives; P, parity; PA, paternal age; PAC, physical activity; PCP, personal car possession; R, race; RY, reference year; SF, sampling fractions; SP, severe prematurity; TM, twin
membership.

Titus-Ernstoff43

Vatten=Norway

2006 Cohort study

Troisi=USA44

42

2004 Case-control

Hodgson=USA41

Barba=USA

2006 Case-control

2006 Case-control

2003 Case-control

Park=Poland13

40

Cancer registry=
population-based cohort
Cancer registry=
population based cohort
Cancer registry=
hospital control
Hospital born birth cohort
Cancer registry=
population control
Cohort case=control

Sources of cases
and controls

2004 Nested
case-control
2003 Cohort study Cancer registry

2001 Cohort study
2000 Case-control

1997 Case-control

2006 Cohort study

24

2004 Cohort study

Michels=USA11

Mellemkjær=Denmark

38

McCormack=Sweden12

Lahmann=Sweden37

Hilakivi-Clarke=Finland
Innes=USA9

Ekbom=Sweden23

Ahlgren=Denmark

15

2001 Cohort study

Andersson=Sweden45

Study design

Year

Study=country

Table 1. Characteristics of Studies Included in the Meta-Analysis

2000

2007

1999

2001

Stavola=UK19

Löf=Sweden21

Mogren=Sweden30

Hubinette=Sweden32

Kaijser=Sweden

31

2001

2003

Kaijser=Sweden35

Ahlgren=Denmark

2005

2003

Ahlgren=Denmark17

McCormack=Sweden36

1992

Ekbom=Sweden22

2007

1998

Sanderson=USA20

Ahlgren=Denmark34

2005

Vatten=Norway33

2006

1996

Michels=USA10

16

Year

Study=country

Case-control

Case-control

Cohort study

Cohort study

Cohort study

Cohort study

Cohort study

Cohort study

Cohort study

Nested
case-control
Cohort study

Case-control

Nested
case-control
Cohort study

Study design

Cancer registry=
population-based female twins
Cancer registry=population-based
opposite-sexed twins

Cancer registry=
population-based cohort

National survey of Health
and Development
National health registers=Women’s
Lifestyle and Health study

Cancer registry=
population-based cohort

Cancer registry=
population-based cohort

Cancer registry=population
control
Cancer registry=
population-based cohort
Cancer registry=
population-based cohort
Cancer registry=
population-based cohort

Cancer registry=
population control

Cancer registry=
population-based cohort

NHS cohort

Sources of cases
and controls

Twin registry

Twin registry

Birth registry

Questionnaire

Birth records

Medical record

Medical record

School health
records
School health
records
School health
records

Medical record

Questionnaire

Medical record

Questionnaire

Source of birth
weight

Born 1926–1967

Born 1886–1956

Born 1955–1990

Diagnosed 1991–2003

Born March 3–9,1946

Born 1925–1949

Born 1915–1929

Born 1930–1975

Born 1930–1975

Born 1930–1975

Born 1874–1954

Diagnosed 1983–1992,
age under 45

Born 1921–1945
and 1946–1965
Born 1920–1958

Case recruitment
period

90

96

57

657

37

39

2,685

12,540

3340

2340

458

510

312

582

No.
of cases

Table 2. Excluded Studies of Birth Weight and Breast Cancer

180

184

Unavailable

38,566

2,221

1,483

11,529

6,975,553

3,333,359

3,266,070

1,655

436

16,016

2,151

Sample
size

Overlap
with Michels=USA=200611
Overlap
with Vatten=Norway=
200242 and no adequate
information for either
‘‘dichotomous comparisons’’
or ‘‘trend analysis’’
Overlap with Sanderson=USA=199639;
part of data concerning breast
cancer risk and only for
premenopausal women
Overlap
with Ekbom=Sweden=199723
Overlap
with Ahlgren=Denmark=200415
A reprint of
Ahlgren=Denmark=200415
Overlap with
Ahlgren=Denmark=200415;
no adequate information
and evaluate other cancers
including breast cancer
Duplication of
data with McCormack=
Sweden=200312 on breast
cancer and better controlling
for confounding factors
No adequate information
for either ‘‘dichotomous
comparisons’’ or ‘‘Trend analysis’’
Case-referent and different
birth weight categories
No adequate information
for either ‘‘dichotomous
comparisons’’ or ‘‘Trend analysis’’
Different birth weight
categories and inadequate
information
Different population
(twins)
Different population
(opposite-sexed twins)

Reason for exclusion

BIRTH WEIGHT AND BREAST CANCER
For each fixed effects of ORs, we quantified the degree
of heterogeneity in the measures across studies with a
Q-statistic, which follows the chi-square distribution with degrees of freedom (df ) equal to the number of included studies
minus 1.49 In this study, if the p value of the Q-statistic was
<0.1, we considered studies to exhibit significant statistical
heterogeneity.50 In this case, a random-effects OR is reported.
The random-effects OR is also a weighted average of studyspecific ORs that considers heterogeneity and can be a reasonable summary effect estimate of the effect of birth weight
on breast cancer when heterogeneity exists across studies. In
addition, we also calculated the I2-statistic, which is equal to
the Q-statistic minus the df and then divided by the Q-statistic
itself. Its CI was also calculated using the method described
by Higgins and Thompson.51 The I2-statistic is a quantitative measure of the degree of between-study heterogeneity.
Smaller values of the I2-statistic suggested lower betweenstudy heterogeneity (0 in I2-statistic suggests no heterogeneity, and larger values indicate increasing heterogeneity).52
Publication bias. The funnel plot method was applied to
determine if there was publication bias among the included
studies.53 The funnel plot includes the log of the ORs as the
x-axis and the standard error (SE) of the log of ORs as the
y-axis. If the plot is asymmetrical, it is interpreted to imply
that publication bias is present. This method provides a direct
visual inspection.
Results
Description of studies
The 18 studies included in the meta-analysis were published between 1996 and 2008. The study populations in-
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cluded participants from the United States,9,11,39–41,43,44
Europe,12,15,23,24,37,38,42,45 and China,18 for a total of 16,424
women with breast cancer. The cases in these studies were
primarily obtained from cancer registries, hospital records, or
both. Birth weight was ascertained from birth records or interviews and questionnaires (Table 1).
Birth weight and breast cancer
Fifteen studies provided estimates of the association between risk of breast cancer and birth weight using dichotomous comparisons (highest vs. lowest). Among them,
8 studies presented the ORs or RRs for the effect of highest
birth weight on breast cancer among all women, regardless of
menopausal status. Figure 1 shows the forest plot for the
study-specific ORs or RRs of these studies and the summary
estimate across them. All 8 studies included in this metaanalysis suggested a positive association between highest
birth weight and breast cancer risk, although the association
was statistically significant in only 2 of the studies (summary
fixed-effect OR 1.20, 95% CI 1.08, 1.34 for highest vs. lowest
birth weight). There was little heterogeneity in effect estimates
across the reviewed studies (Q-statistic ¼ 4.52, p for heterogeneity ¼ 0.72; I2-statistic ¼ 0, 95% CI 0, 50%).
Figures 2 shows the forest plots of the association estimates of highest birth weight on premenopausal and postmenopausal breast cancer and the summary estimates across them.
Altogether, 9 studies provided adequate information to ascertain the association between birth weight and premenopausal
breast cancer risk (Fig. 2A). Because of the heterogeneity
of the estimates (Q-statistic ¼ 15.89, p for heterogeneity<0.05,
I2-statistic ¼ 50%, 95% CI 0, 76.5%), a random-effects summary OR was calculated. The random-effects summary OR

FIG. 1. Odds ratio with corresponding 95% confidence intervals for breast cancer in women of all ages with highest (>4000 g
or 8.5 lb) vs. lowest (<2500 g or 3000 g) birth weight. The Q-statistic and I2-statistic tests indicated no heterogeneity (Qstastistic ¼ 4.52, p for heterogeneity ¼ 0.72, I2-statistic ¼ 0, 95% CI 0, 50%). The fixed-effects odds ratio is 1.20 (95% CI 1.08, 1.34).
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FIG. 2. (A) Odds ratio with corresponding 95% confidence intervals for premenopausal breast cancer risk with high (>4000 g
or 8.5 lb) vs. lowest (<2500 g or 3000 g) birth weight. The Q-statistic and I2-statistic tests indicated heterogeneity across studies (Q-statistic ¼ 15.89, p for heterogeneity <0.05, I 2-statistic ¼ 50%, 95%CI 0, 76.5%). The random-effects odds ratio is 1.37 (95%
CI 0.98, 1.92). (B) Odds ratio with corresponding 95% confidence intervals for postmenopausal breast cancer risk with highest
vs. lowest birth weight. The Q-statistic and I2-statistic tests indicated heterogeneity across studies (Q-statistic ¼ 12.0, p for
heterogeneity <0.05, I2-statistic ¼ 58%, 95%CI 0, 83%). The random-effects odds ratios is 1.13 (95% CI 0.85, 1.51).
was 1.37 (95% CI 0.98, 1.92) for the effect of highest birth weight
(4,000 g or 8.5 lb) compared with the lowest birth weight
(<2500 g, <5.5 lb, or <3000 g). Only 6 studies provided adequate information on postmenopausal breast cancer and birth
weight to allow the dichotomous comparison (Fig. 2B). The
heterogeneity in the association estimates from these 6 studies
was also significant (Q-statistic ¼ 12.0, p for heterogeneity
<0.05, I2-statistic ¼ 58%, 95%CI 0, 83%). The random-effects
OR was 1.13 (95%CI 0.85, 1.51).
Trend analysis
We conducted a separate meta-analysis to determine if
there is a log-linear effect of birth weight on breast cancer risk.
This analysis included 16 studies, which met the inclusion
criteria for the trend analysis, that is, the effect estimates of
breast cancer risk associated with a 1 kg increase in birth
weight being presented or estimated using the Greenland
and Longnecker method,46 and provided 19 effect estimates.
Figure 3 shows a forest plot of these study-specific effect estimates and the summary estimate across them. Among the
19 effect estimates, a positive association was found in 13

studies, although the association was statistically significant
in only 5 of the studies. A negative association was observed
in 6 other studies in addition to 1 with a statistically significantly negative association (Fig. 3). There was an overall statistically significant association between breast cancer and
each 1 kg increase in birth weight (random-effects OR 1.07,
95% CI 1.02, 1.12). The effect estimates were heterogeneous
across studies (Q-statistic ¼ 30.02, p for heterogeneity <0.05,
I2-statistic ¼ 40%, 95% CI 0, 65%). The high heterogeneity
among the studies seemed to be a result of the effect among
African Americans in the study by Hodgson et al.41 The
overall heterogeneity became nonsignificant (Q-statistic ¼
24.9, p for heterogeneity >0.10, I2-statistic ¼ 30%, 95% CI 0,
62%) after excluding the study. However, the exclusion did
not substantially change the summary effect estimate (fixedeffects OR ¼ 1.08, 95% CI 1.02, 1.13)
Publication bias
Visual inspection of the funnel plots does not suggest
substantial publication bias suggested in this meta-analysis
(data not shown).

BIRTH WEIGHT AND BREAST CANCER
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FIG. 3. Study-specific effect estimates for breast cancer risk per 1 kg increase in birth weight. The Q-statistic and I2-statistic
tests indicated the presence of heterogeneity across studies (Q-statistic ¼ 30.02, p for heterogeneity <0.05, I2-statistic ¼ 40%,
95% CI 0, 65%). The random-effects OR was 1.07 (95% CI 1.02, 1.12) apre, premenopausal women; post, postmenopausal
women. bHodgson’s 2004 study provided effect estimates for white and African American women, respectively.

Discussion
This meta-analysis of 18 epidemiological studies showed a
significant, albeit modest in magnitude, summary effect of
breast cancer risk with high birth weight (4000 g or 8.5 lb)
compared with the lowest category of birth weight (<2500 g
or 3000 g) among women of all ages. Our results (OR ¼ 1.37,
95% CI 0.98, 1.92 for premenopausal women; OR ¼ 1.13, 95%
CI 0.85, 1.51 for postmenopausal women) differed from the
estimates from the meta-analysis conducted by Michels and
Xue in 200627 (OR ¼ 1.25, 95% CI 1.14, 1.38 for premenopausal
women; OR ¼ 1.04, 95% CI 0.91, 1.19 for postmenopausal
women), with our estimates higher and approaching significance for premenopausal women. The alternative analytic
strategy employed in the study and inclusion of additional
studies are the likely reasons behind these difference. In terms
of methodological differences, we employed a random-effects
model rather than a fixed-effects model to provide a summary
estimate accounting for the heterogeneity across the studies.
We also used more consistent and clear definitions of highest
(birth weight >4000 g)and referent (birth weight<2500 g or

<3000 g) categories in our analysis. In addition, we have an
alternative approach to Michels and Xue27 for combining effect estimates based on categorical birth weight together
with the effect estimates based on continuous birth weight to
generate a single summary estimate. In our analysis, we analyzed both the categorical and continuous measurement, but
we did them separately. In addition to these methodological
differences, we included 3 publications from 200611,13,40 that
have become available since the publication of Michels and
Xue.27
The findings from this meta-analysis demonstrated a
clear dose-response relation between birth weight and breast
cancer risk after accounting for the heterogeneity across the
studies. These results indicated that breast cancer risk increased approximately 7% per 1 kg increase in birth weight.
Our results were consistent with the findings of the WCRF
report,29 which indicated that breast cancer risk increased 8%
per 1 kg increase in birth weight (based on 6 cohort studies).
Another pool analysis14 indicated that breast cancer risk increased 6% per l SD (0.5 kg) increase in birth weight; our estimate is slightly lower but comparable. Our study adds
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additional information that pooled analyses might be unable
to quantify. We were able to include additional studies that
measured birth weight only in categorical variables by using
the Greenland and Longnecker method46 to estimate the doseresponse relationship. In our meta-analysis, although the effect estimate among premenopausal women is larger in
magnitude than the effect among postmenopausal women,
the association was not statistically significant. Even with the
inclusion of additional studies that provided adequate information for stratification by menopausal status and applying
the Greenland and Longnecker methods for estimating doseresponse relationships incorporating categorical measures,
our findings remain consistent with the earlier meta-analyses.
Birth weight as a proxy indicator of intrauterine environment has been linked with several hormone-related cancers,
including testicular cancer,54–56 prostate cancer,57–59 and breast
cancer, and other types of cancers, such as childhood leukemia.60–62 Although the underlying biological mechanisms
that link high birth weight to a higher risk of breast cancer are
still ambiguous, the findings from recent animal studies and
epidemiological studies might provide clues to elucidate the
association. We know that estrogen plays a major role in the
etiology of breast cancer.63,64 Hence, hormonal exposures in
early life might have a particularly significant influence on the
subsequent breast cancer risk in adult life because the fetus is
particularly susceptible to transient hormonal exposure and
the change in the hormonal environment of the fetus alters the
development of target organs by exerting lifelong effects.65,66
In animal experiments, exposure to estrogens during fetal or
early postnatal development can increase mammary tumorigenesis by changing both proliferation and differentiation of
the mammary gland.67 Several epidemiological studies found
that dizygotic twins who were exposed to more estrogens
in utero because of two placentas have a higher risk of breast
cancer than singleton births.68–70 Pregnancy estrogen levels have been reported positively associated with birth
weight.71–73 Therefore, high birth weight, like twinning,
might be a proxy variable of early life exposure to high levels
of pregnancy estrogens, as Trichopoulos proposed.8
Another potential mechanism is that women with high
birth weight may merely have a higher number of mammary
gland cells at risk for transformation and, thus, have an increased subsequent breast cancer risk.74 Findings from the
study by Cerhan et al.75 that birth weight was positively associated with mammographic breast density and dense area
among women support the hypothesis because mammographic density is strongly correlated with mammary gland
mass, which is also potentially associated with the mammary
cells at risk for transformation.74 However, the specific biological mechanisms remain poorly understood. An important
next step is to investigate more thoroughly plausible biological pathways that may explain the relationship between birth
weight and breast cancer risk.
Some potential limitations of the meta-analysis should be
considered. Publication bias is always a serious concern for
meta-analyses; however, visual inspection of the funnel plots
did not provide any obvious evidence of publication bias
across studies. Many included studies also investigated additional intrauterine environmental factors associated with
breast cancer, which could increase the chance of inclusion
of studies with a nonsignificant association between birth
weight and breast cancer and, consequently, reduce the po-
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tential publication bias. Bias within studies, such as information bias or selection bias, could also have influenced the
validity of this meta-analysis study. In 7 of the studies we
included, birth weight information was obtained from interviews or questionnaires. Recall bias might be a major problem
among these studies. However, 1 study indicated that the
birth information directly reported from the mother is as
precise as the information from medical records.76 Therefore,
the influence of recall bias in these studies could be negligible.
Misclassification of cases might stem from the method of
ascertaining the outcome through cancer registries as the result of possible incomplete reporting,77–79 errors in the registry,80–82 mismatched cases,83 residential mobility, and
subsequent losses to follow-up. Although the potential impact
of this problem is difficult to evaluate, there is no reason to
believe that the misclassification is differential with regard to
the breast cancer outcome among different birth weight categories. Finally, the inconsistent findings across the included
studies might result from the differences in sample sizes,
study populations, measurement cutoff points of birth
weight, or other study design characteristics, such as inclusion
of different potential confounding variables.
Overall, the results of this study supported the hypothesis
that birth weight plays an important role in determining
breast cancer risk in adult life. In particular, our findings indicated that breast cancer risk increased approximately 7%
per 1 kg increase in birth weight. These results underscore the
importance of conducting additional studies to clarify the
underlying biological mechanisms that may further our understanding of the relationship between birth weight and
breast cancer. This meta-analysis did not reveal effect modification by menopausal status, and additional studies are
warranted because of the limited number of studies that
stratified by this factor. In addition, more studies with improved research methods and analytic approaches are warranted to address the question of whether birth weight is more
strongly associated with early-onset than with later-onset
breast cancer.
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